You are here

India Resilience System Working Group

Primary tabs

The India Resilience System Working Group is focused on building health, human security, resilience and sustainability in India.

The mission of the India Resilience System Working Group is to build health, human security, resilience, and sustainability in India.

Members

gsharma Kathy Gilbeaux mdmcdonald

Email address for group

india-resilience-system-working-group@m.resiliencesystem.org

The Coronavirus spread threatens Southeast Asia and elsewhere

As the virus threatens Southeast Asia, the spread of new variants continues to be a danger everywhere

After a devastating year with wave after wave of coronavirus infections around the world, new cases and deaths are falling in many of the Western nations that were once among the hardest hit. But while the virus recedes in wealthy nations with robust vaccination campaigns, it is pummeling India and threatening to swamp Southeast Asian countries that until now had largely kept the virus at bay.

Taken together, the opposing regional trends add up to a leveling of global daily new cases at “an unacceptably high plateau” that leaves the world in continuing danger, the director general of the World Health Organization, Tedros Adhanom Ghebreyesus, said on Monday.

In Southeast Asia, Dr. Tedros noted that “cases and deaths are still increasing rapidly.”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO says India Covid variant of 'global concern'

The World Health Organization (WHO) has classified the coronavirus variant first found in India last year as a "variant of global concern".

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Indian government concerned about "black fungus" in COVID-19 patients

'Black Fungus' Complication Adds to India's COVID Woes

BENGALURU (Reuters) - The Indian government has told doctors to look out for signs of mucormycosis or "black fungus" in COVID-19 patients as hospitals report a rise in cases of the rare but potentially fatal infection.

The state-run Indian Council of Medical Research (ICMR) said at the weekend that doctors treating COVID-19 patients, diabetics and those with compromised immune systems should watch for early symptoms including sinus pain or nasal blockage on one side of the face, one-sided headache, swelling or numbness, toothache and loosening of teeth.

The disease, which can lead to blackening or discolouration over the nose, blurred or double vision, chest pain, breathing difficulties and coughing blood, is strongly linked to diabetes. And diabetes can in turn be exacerbated by steroids such as dexamethasone, used to treat severe COVID-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Description of how India's major vaccine producer fell short of promises to inoculate the world's poor

 

NEW DELHI — Adar Poonawalla made big promises. The 40-year-old chief of the world’s largest vaccine maker pledged to take a leading role in the global effort to inoculate the poor against Covid-19. His India-based empire signed deals worth hundreds of millions of dollars to make and export doses to suffering countries.

Those promises have fallen apart. India, engulfed in a coronavirus second wave, is laying claim to his vaccines. Other countries and aid groups are now racing to find scarce doses elsewhere.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.625 seconds.